Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Biol Chem ; 291(22): 11787-99, 2016 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-27044743

RESUMEN

Mycobacterium tuberculosis is protected by an unusual and highly impermeable cell envelope that is critically important for the successful colonization of the host. The outermost surface of this cell envelope is formed by capsular polysaccharides that play an important role in modulating the initial interactions once the bacillus enters the body. Although the bioenzymatic steps involved in the production of the capsular polysaccharides are emerging, information regarding the ability of the bacterium to modulate the composition of the capsule is still unknown. Here, we study the mechanisms involved in regulation of mycobacterial capsule biosynthesis using a high throughput screen for gene products involved in capsular α-glucan production. Utilizing this approach we identified a group of mutants that all carried mutations in the ATP-binding cassette phosphate transport locus pst These mutants collectively exhibited a strong overproduction of capsular polysaccharides, including α-glucan and arabinomannan, suggestive of a role for inorganic phosphate (Pi) metabolism in modulating capsular polysaccharide production. These findings were corroborated by the observation that growth under low Pi conditions as well as chemical activation of the stringent response induces capsule production in a number of mycobacterial species. This induction is, in part, dependent on σ factor E. Finally, we show that Mycobacterium marinum, a model organism for M. tuberculosis, encounters Pi stress during infection, which shows the relevance of our findings in vivo.


Asunto(s)
Cápsulas Bacterianas/metabolismo , Embrión no Mamífero/metabolismo , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium marinum/efectos de los fármacos , Fosfatos/farmacología , Polisacáridos/metabolismo , Animales , Cápsulas Bacterianas/efectos de los fármacos , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/microbiología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Pez Cebra
2.
J Biol Chem ; 290(52): 31077-89, 2015 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-26546681

RESUMEN

Rv2466c is a key oxidoreductase that mediates the reductive activation of TP053, a thienopyrimidine derivative that kills replicating and non-replicating Mycobacterium tuberculosis, but whose mode of action remains enigmatic. Rv2466c is a homodimer in which each subunit displays a modular architecture comprising a canonical thioredoxin-fold with a Cys(19)-Pro(20)-Trp(21)-Cys(22) motif, and an insertion consisting of a four α-helical bundle and a short α-helical hairpin. Strong evidence is provided for dramatic conformational changes during the Rv2466c redox cycle, which are essential for TP053 activity. Strikingly, a new crystal structure of the reduced form of Rv2466c revealed the binding of a C-terminal extension in α-helical conformation to a pocket next to the active site cysteine pair at the interface between the thioredoxin domain and the helical insertion domain. The ab initio low-resolution envelopes obtained from small angle x-ray scattering showed that the fully reduced form of Rv2466c adopts a "closed" compact conformation in solution, similar to that observed in the crystal structure. In contrast, the oxidized form of Rv2466c displays an "open" conformation, where tertiary structural changes in the α-helical subdomain suffice to account for the observed conformational transitions. Altogether our structural, biochemical, and biophysical data strongly support a model in which the formation of the catalytic disulfide bond upon TP053 reduction triggers local structural changes that open the substrate binding site of Rv2466c allowing the release of the activated, reduced form of TP053. Our studies suggest that similar structural changes might have a functional role in other members of the thioredoxin-fold superfamily.


Asunto(s)
Antituberculosos/química , Proteínas Bacterianas/química , Modelos Moleculares , Mycobacterium tuberculosis/química , Profármacos/química , Multimerización de Proteína , Proteínas Bacterianas/genética , Cristalografía por Rayos X , Mycobacterium tuberculosis/genética , Oxidación-Reducción , Unión Proteica , Estructura Cuaternaria de Proteína , Estructura Terciaria de Proteína
3.
Infect Immun ; 80(9): 3132-44, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22733573

RESUMEN

The proteins belonging to the WhiB superfamily are small global transcriptional regulators typical of actinomycetes. In this paper, we characterize the role of WhiB5, a Mycobacterium tuberculosis protein belonging to this superfamily. A null mutant was constructed in M. tuberculosis H37Rv and was shown to be attenuated during both progressive and chronic mouse infections. Mice infected with the mutant had smaller bacillary burdens in the lungs but a larger inflammatory response, suggesting a role of WhiB5 in immunomodulation. Most interestingly, the whiB5 mutant was not able to resume growth after reactivation from chronic infection, suggesting that WhiB5 controls the expression of genes involved in this process. The mutant was also more sensitive than the wild-type parental strain to S-nitrosoglutathione (GSNO) and was less metabolically active following prolonged starvation, underscoring the importance of GSNO and starvation in development and maintenance of chronic infection. DNA microarray analysis identified 58 genes whose expression is influenced by WhiB5, including sigM, encoding an alternative sigma factor, and genes encoding the constituents of two type VII secretion systems, namely, ESX-2 and ESX-4.


Asunto(s)
Proteínas Bacterianas/metabolismo , Mycobacterium tuberculosis/patogenicidad , Factor sigma/metabolismo , Factores de Virulencia/metabolismo , Animales , Carga Bacteriana , Proteínas Bacterianas/genética , Modelos Animales de Enfermedad , Eliminación de Gen , Perfilación de la Expresión Génica , Pulmón/microbiología , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Análisis por Micromatrices , Mycobacterium tuberculosis/genética , Factor sigma/genética , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patología , Virulencia , Factores de Virulencia/genética
4.
Antimicrob Agents Chemother ; 56(4): 2074-83, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22232275

RESUMEN

Efflux pumps extrude a wide variety of chemically unrelated compounds conferring multidrug resistance and participating in numerous physiological processes. Mycobacterium tuberculosis possesses many efflux pumps, and their roles in drug resistance and physiology are actively investigated. In this work we found that tap mutant cells showed changes in morphology and a progressive loss of viability upon subcultivation in liquid medium. Transcriptome analysis in Mycobacterium bovis BCG revealed that disruption of the Rv1258c gene, encoding the Tap efflux pump, led to an extensive change in gene expression patterns during stationary phase, with no changes during exponential growth. In stationary phase, Tap inactivation triggered a general stress response and led to a general repression of genes involved in cell wall biosynthesis, in particular the formation of the peptidoglycan; this suggested the accumulation of an unknown Tap substrate that reaches toxic concentrations during stationary phase. We also found that both disruption and overexpression of tap altered susceptibility to many clinically approved antibiotics in M. bovis BCG. Acriflavine and tetracycline accumulation assays and carbonyl cyanide m-chlorophenylhydrazone (CCCP) potentiation experiments demonstrated that this phenotype was due to an active efflux mechanism. These findings emphasize the important role of the Tap efflux pump in bacterial physiology and intrinsic drug resistance.


Asunto(s)
Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteínas de Transporte de Membrana/genética , Proteínas de Transporte de Membrana/metabolismo , Mycobacterium bovis/genética , Mycobacterium bovis/metabolismo , Acriflavina/metabolismo , Acriflavina/farmacología , Antibacterianos/metabolismo , Antibacterianos/farmacología , Benzofenoneido , Southern Blotting , Carbonil Cianuro m-Clorofenil Hidrazona/farmacología , ADN Bacteriano/genética , Farmacorresistencia Bacteriana/genética , Colorantes Fluorescentes , Genes Transgénicos Suicidas , Análisis por Micromatrices , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Mycobacterium bovis/crecimiento & desarrollo , Plásmidos/genética , Reacción en Cadena de la Polimerasa , ARN Bacteriano/biosíntesis , ARN Bacteriano/genética , Tetraciclina/metabolismo , Tetraciclina/farmacología , Desacopladores/farmacología
5.
Nucleic Acids Res ; 38(12): e134, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20406773

RESUMEN

Tightly regulated gene expression systems represent invaluable tools for studying gene function and for the validation of drug targets in bacteria. While several regulated bacterial promoters have been characterized, few of them have been successfully used in mycobacteria. In this article we describe the development of a novel repressible promoter system effective in both fast- and slow-growing mycobacteria based on two chromosomally encoded repressors, dependent on tetracycline (TetR) and pristinamycin (Pip), respectively. This uniqueness results in high versatility and stringency. Using this method we were able to obtain an ftsZ conditional mutant in Mycobacterium smegmatis and a fadD32 conditional mutant in Mycobacterium tuberculosis, confirming their essentiality for bacterial growth in vitro. This repressible promoter system could also be exploited to regulate gene expression during M. tuberculosis intracellular growth.


Asunto(s)
Regulación Bacteriana de la Expresión Génica , Mycobacterium smegmatis/genética , Mycobacterium tuberculosis/genética , Regiones Promotoras Genéticas , Proteínas Represoras/metabolismo , Proteínas Bacterianas/genética , Proteínas del Citoesqueleto/genética , Mutación , Operón , Pristinamicina/farmacología , Tetraciclinas/farmacología
6.
J Bacteriol ; 190(17): 5963-71, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18606740

RESUMEN

The extracytoplasmic factor (ECF) sigma factor sigma(E) is one of the most studied sigma factors of Mycobacterium tuberculosis. It has been shown to be involved in virulence as well as in survival under conditions of high temperature, alkaline pH, and exposure to detergents and oxidative stress. Unlike many ECF sigma factors, sigma(E) does not directly regulate the transcription of its own gene. Two promoters have been identified upstream of the sigE gene; one is regulated by the two-component system MprAB, while the other has been shown to be sigma(H) dependent. In this paper, we further characterize the regulation of sigma(E) by identifying its anti-sigma factor and a previously unknown promoter. Finally, we show that sigE can be translated from three different translational start codons, depending on the promoter used. Taken together, our data demonstrate that sigma(E) not only is subjected to complex transcriptional regulation but is also controlled at the translational and posttranslational levels.


Asunto(s)
Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica , Mycobacterium tuberculosis/genética , Factor sigma/genética , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/fisiología , Secuencia de Bases , Diamida/farmacología , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/metabolismo , Regiones Promotoras Genéticas/genética , Biosíntesis de Proteínas/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor sigma/metabolismo , Factor sigma/fisiología , Dodecil Sulfato de Sodio/farmacología , Sitio de Iniciación de la Transcripción , Transcripción Genética/efectos de los fármacos
7.
PLoS One ; 9(9): e108893, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25268826

RESUMEN

SigE represents one of the best characterized alternative sigma factors of Mycobacterium tuberculosis, playing a major role in the response to several environmental stresses and essential for growth in macrophages and virulence. In previous work we demonstrated that a mutant of M. tuberculosis in which the sigE gene was disrupted by a cassette conferring hygromycin resistance is a promising vaccine candidate conferring better protection than Mycobacterium bovis BCG in a mouse model of infection. In this work we describe the construction of a new unmarked mutant in which the entire sigE gene was disrupted in order to fulfill the requirements of the Geneva consensus to enter clinical trials. After showing that the phenotype of this mutant is superimposable to that of the previous one, we further characterized the role of SigE in the M tuberculosis intracellular behavior showing that it is dispensable for replication in human pneumocytes, while it is essential for the arrest of phagosome maturation in THP-1-derived macrophages.


Asunto(s)
Proteínas Bacterianas/metabolismo , Mycobacterium tuberculosis/metabolismo , Fagosomas/metabolismo , Factor sigma/metabolismo , Células Epiteliales Alveolares/microbiología , Proteínas Bacterianas/genética , Línea Celular , Escherichia coli/metabolismo , Humanos , Macrófagos/inmunología , Macrófagos/metabolismo , Macrófagos/microbiología , Mutación , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/patogenicidad , Óxido Nítrico/metabolismo , Fenotipo , Factor sigma/genética , Virulencia
8.
Vaccine ; 32(32): 4051-8, 2014 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-24886957

RESUMEN

Protein-subunit vaccines as boosting strategies against tuberculosis (TB) infection are currently in the pipeline of TB vaccine research. Their main limitation is represented by their poor immunogenicity, which makes it necessary to couple protein-subunits with adjuvant molecules. In this study, we employed replication-deficient invasive Escherichia coli strains to deliver Mycobacterium tuberculosis proteins to the cytoplasm of non-phagocytic eukaryotic cells using various priming and prime-boosting vaccination protocols. Our results demonstrate that intranasal administration of invasive E. coli expressing the M. tuberculosis protective antigen MPT64 to mice primed with a recombinant BCG strain over-expressing MPT64 on its surface, decrease bacterial burden in mice spleens. Our data suggest that replication-deficient invasive E. coli may represent a suitable platform for BCG/rBCG priming followed by homologous-boosting immunization strategies.


Asunto(s)
Antígenos Bacterianos/inmunología , Escherichia coli , Inmunización Secundaria/métodos , Vacunas contra la Tuberculosis/inmunología , Tuberculosis/prevención & control , Administración Intranasal , Animales , Vacuna BCG/inmunología , Carga Bacteriana , Femenino , Células HeLa , Humanos , Ratones Endogámicos C57BL , Mycobacterium tuberculosis , Proteínas Recombinantes/inmunología , Bazo/microbiología
9.
J Bacteriol ; 189(3): 730-40, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17098899

RESUMEN

The proteins belonging to the Fur family are global regulators of gene expression involved in the response to several environmental stresses and to the maintenance of divalent cation homeostasis. The Mycobacterium tuberculosis genome encodes two Fur-like proteins, FurA and a protein formerly annotated FurB. Since in this paper we show that it represents a zinc uptake regulator, we refer to it as Zur. The gene encoding Zur is found in an operon together with the gene encoding a second transcriptional regulator (Rv2358). In a previous work we demonstrated that Rv2358 is responsible for the zinc-dependent repression of the Rv2358-zur operon, favoring the hypothesis that these genes represent key regulators of zinc homeostasis. In this study we generated a zur mutant in M. tuberculosis, examined its phenotype, and characterized the Zur regulon by DNA microarray analysis. Thirty-two genes, presumably organized in 16 operons, were found to be upregulated in the zur mutant. Twenty-four of them belonged to eight putative transcriptional units preceded by a conserved 26-bp palindrome. Electrophoretic mobility shift experiments demonstrated that Zur binds to this palindrome in a zinc-dependent manner, suggesting its direct regulation of these genes. The proteins encoded by Zur-regulated genes include a group of ribosomal proteins, three putative metal transporters, the proteins belonging to early secretory antigen target 6 (ESAT-6) cluster 3, and three additional proteins belonging to the ESAT-6/culture filtrate protein 10 (CFP-10) family known to contain immunodominant epitopes in the T-cell response to M. tuberculosis infection.


Asunto(s)
Proteínas Bacterianas/genética , Mycobacterium tuberculosis/genética , Regulón , Proteínas Represoras/genética , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Sitios de Unión , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Desoxirribonucleasa I/metabolismo , Regulación Bacteriana de la Expresión Génica , Modelos Genéticos , Datos de Secuencia Molecular , Mycobacterium tuberculosis/patogenicidad , Análisis de Secuencia por Matrices de Oligonucleótidos , Unión Proteica , Proteínas Represoras/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Virulencia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA